← Back to company shares
AP
Apex Ventures
APVE · BiotechnologyApplied biotechnology research aimed at treating chronic and rare conditions. Backed by Apex Ventures's operating track record in the biotechnology space.
Price / Share
$497.06
Shares Sold
177,815 / 800,000
Shares Remaining
622,185
22% subscribed
Log in to purchase shares